1834 Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
1834 Investment Advisors's GILD Position: Q3 2022 in Review
1834 Investment Advisors sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 1,100 shares — an estimated $68K sold.
1834 Investment Advisors first reported a position in GILD in Q1 2015 and held it in 23 quarters. The position peaked at $3.14M in Q2 2015. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.
- 1834 Investment Advisors reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
- 1834 Investment Advisors sold 1,100 Gilead Sciences shares in Q3 2022, an estimated $68K.
- 1834 Investment Advisors first reported a position in Gilead Sciences in Q1 2015 and held it in 23 quarters.
- 1834 Investment Advisors's Gilead Sciences position peaked at $3.14M in Q2 2015.
- 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.
Based on 1834 Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.